EXEL Exelixis Inc
12,011
$21.37
$0.39
(1.79%)
| Watchers | 12,011 |
| 52-Wk Low | $18.64 |
| 52-Wk High | $24.34 |
| Market Cap | $6.22B |
| Volume | 1.69M |
| 52-Wk High | $24.34 |
| 52-Wk Low | $18.64 |
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in MayBusiness Wire • 5 days ago
Exelixis, Inc. (Nasdaq: EXEL) today announced that members of the companys management team will participate in fireside chats at the following investor conferences in May: BofA Securities 2024 Health...
Share to Feed
Latest Ratings for EXEL
DateFirmActionFromTo Feb 2022HC Wainwright & Co.MaintainsBuy Nov 2021RBC CapitalMaintainsOutperform Nov 2021HC Wainwright & Co.MaintainsBuy
View More Analyst Ratings...
Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the first quarter of 2024, provided an update on progress toward achieving key corporate objectives, and detailed its recent and...
Exelixis, Inc. (Nasdaq: EXEL) announced today that its first quarter 2024 financial results will be released on Tuesday, April 30, 2024 after the markets close. At 5:00 p.m. ET / 2:00 p.m. PT...
Latest Ratings for EXEL
DateFirmActionFromTo Feb 2022HC Wainwright & Co.MaintainsBuy Nov 2021RBC CapitalMaintainsOutperform Nov 2021HC Wainwright & Co.MaintainsBuy
View More Analyst Ratings...
Exelixis (NASDAQ:EXEL - Get Free Report) and JATT Acquisition (NYSE:JATT - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based...
An update from Exelixis (EXEL) is now available. Jacqueline Wright has announced that she will not seek re-election to Exelixis, Inc.'s Board of Di...
Exelixis, Inc. (NASDAQ:EXEL Get Free Report) Director Alan M. Garber sold 19,205 shares of the businesss stock in a transaction that occurred on Thursday, March 21st. The shares were...
Exelixis: Patent Woes And Challenging Market Dynamics Make For A Testy 2024...
Hudson Bay Capital Management LP lessened its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL Free Report) by 7.7% during the third quarter, according to the company in its most recent...